Arsenal

Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment

Arsenal July 9, 2024

BioCity’s SC0062 Meets Primary Endpoint in Phase 2 IgA Nephropathy Trial

Arsenal July 8, 2024

Doer Biologics Completes Enrollment in DR10624 Obesity and Hypertriglyceridemia Trial

Arsenal July 5, 2024

Calliditas Partner Initiates Phase 3 Nefecon Trial in Japan

Arsenal July 4, 2024

Genentech Reports Results of Tiragolumab Lung Cancer Trial (SKYSCRAPER-06)

Arsenal July 4, 2024

WuXi Scrutiny Opens Doors for India’s Biotech CDMOs

Arsenal July 3, 2024

Gilead’s Trodelvy Faces Setbacks in Trials, Remains Key Cancer Drug

Arsenal July 1, 2024

SNIPR Biome Receives Funding to Develop CRISPR-Based EED Treatment

Arsenal June 28, 2024

FDA Issues Complete Response Letter for Patritumab Deruxtecan BLA

Arsenal June 27, 2024

Opinion: Biopharma’s Role in Preparing for the Next Pandemic

Arsenal June 26, 2024

Roche’s OCREVUS® SC with ENHANZE® Approved in Europe for Multiple Sclerosis

Arsenal June 25, 2024

NeuroBo’s DA-1726 Outperforms Survodutide in Weight Loss and Lipid-Lowering Pre-Clinical Models

Arsenal June 24, 2024

Altimmune Presents Pemvidutide Obesity Trial Data at ADA Scientific Sessions

Arsenal June 24, 2024

Merck, Verona, AbbVie, Rocket Await FDA Decisions in June

Arsenal June 24, 2024

GC Cell Partners with Bifarma, a KALBE Group Affiliate, for Cell Therapy

Arsenal June 20, 2024

SpyBiotech Names Keith Dewedoff as New CFO of Vaccine Biotech

Arsenal June 18, 2024

Accelerating Rare Disease Drug Development Through Regulatory Flexibility

Arsenal June 17, 2024

Regulatory Flexibility: Accelerating Rare Disease Drug Development

Arsenal June 17, 2024

Avidity Biosciences Prices 10.55M Share Public Offering at $38/Share

Arsenal June 14, 2024

InnoCare Presents Robust Pipeline Data at EHA 2024 Hybrid Congress

Arsenal June 14, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA

Arsenal

Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment

BioCity’s SC0062 Meets Primary Endpoint in Phase 2 IgA Nephropathy Trial

Doer Biologics Completes Enrollment in DR10624 Obesity and Hypertriglyceridemia Trial

Calliditas Partner Initiates Phase 3 Nefecon Trial in Japan

Genentech Reports Results of Tiragolumab Lung Cancer Trial (SKYSCRAPER-06)

WuXi Scrutiny Opens Doors for India’s Biotech CDMOs

Gilead’s Trodelvy Faces Setbacks in Trials, Remains Key Cancer Drug

SNIPR Biome Receives Funding to Develop CRISPR-Based EED Treatment

FDA Issues Complete Response Letter for Patritumab Deruxtecan BLA

Opinion: Biopharma’s Role in Preparing for the Next Pandemic

Roche’s OCREVUS® SC with ENHANZE® Approved in Europe for Multiple Sclerosis

NeuroBo’s DA-1726 Outperforms Survodutide in Weight Loss and Lipid-Lowering Pre-Clinical Models

Altimmune Presents Pemvidutide Obesity Trial Data at ADA Scientific Sessions

Merck, Verona, AbbVie, Rocket Await FDA Decisions in June

GC Cell Partners with Bifarma, a KALBE Group Affiliate, for Cell Therapy

SpyBiotech Names Keith Dewedoff as New CFO of Vaccine Biotech

Accelerating Rare Disease Drug Development Through Regulatory Flexibility

Regulatory Flexibility: Accelerating Rare Disease Drug Development

Avidity Biosciences Prices 10.55M Share Public Offering at $38/Share

InnoCare Presents Robust Pipeline Data at EHA 2024 Hybrid Congress

Stay up to date on the latest news

Access the Ideas that Accelerate Innovation

Trending News

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

Popular Categories

Information

Contact Us